These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6373804)

  • 1. [Indefinite survival of pancreatic allografts under cyclosporin A treatment in rats].
    Domergue J; Bouhaddioui N; Barneon G; Marchal G
    J Chir (Paris); 1984 Mar; 121(3):195-201. PubMed ID: 6373804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental pancreas allograft rejection: correlation between histologic and functional rejection and the efficacy of antirejection therapy.
    Schulak JA; Drevyanko TF
    Surgery; 1985 Aug; 98(2):330-7. PubMed ID: 3895543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of segmental pancreatic allografts in dogs receiving cyclosporin A.
    Du Toit DF; Reece-Smith H; McShane P; Denton T; Morris PJ
    Transplantation; 1982 Apr; 33(4):432-7. PubMed ID: 6176055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segmental pancreatic allograft survival in baboons treated with combined irradiation and cyclosporine: a preliminary report.
    du Toit DF; Heydenrych JJ; Smit B; Louw G; Zuurmond T; Laker L; Els D; Weideman A; Wolfe-Coote S; van der Merwe EA
    Surgery; 1985 Apr; 97(4):447-54. PubMed ID: 3885455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to transplanted pancreas in pigs.
    Grace DM; Feindel CM; Harris KA; Inculet RI; Wallace AC; Stiller CR
    Transplant Proc; 1982 Dec; 14(4):649-55. PubMed ID: 6762721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in post-cyclosporin A (CyA) graft acceptance following individual and combined kidney and pancreas transplantation in the rat.
    Vogt P; Wähling K; Klempnauer J
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2843-4. PubMed ID: 2650381
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor-specific antigen and cyclosporine fail to prolong rat pancreas survival.
    Schulak JA; Cooke JC; Herrmann M
    Transplant Proc; 1990 Apr; 22(2):739-40. PubMed ID: 2327026
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit corneal allograft survival following topical administration of cyclosporin A.
    Kana JS; Hoffmann F; Buchen R; Krolik A; Wiederholt M
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):686-90. PubMed ID: 7076412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
    Towpik E; Kupiec-Weglinski JW; Schneider TM; Tyler D; Padberg W; Araneda D; Tilney NL
    Transplantation; 1985 Dec; 40(6):714-8. PubMed ID: 3907046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine and experimental skin allografts: long-term survival in rats treated with low maintenance doses.
    Towpik E; Kupiec-Weglinski JW; Tyler DS; Araujo JL; Schneider TM; Araneda D; Murphy GM; Tilney NL
    Plast Reconstr Surg; 1986 Feb; 77(2):268-76. PubMed ID: 3511482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
    Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
    Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression.
    du Toit D; Muller C; Page B; Louw J
    Microsc Res Tech; 1998 Nov; 43(4):347-55. PubMed ID: 9849976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
    Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
    J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term acceptance of pancreatic allografts in rats during trough level-controlled cyclosporine A treatment.
    Loske G; Timmermann W; Schubert G; Leimenstoll G; Schang T; Stoffregen C; Thiede A
    Transplant Proc; 1987 Oct; 19(5):4334-5. PubMed ID: 3314037
    [No Abstract]   [Full Text] [Related]  

  • 20. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.